Sharp Pain Under the Kneecap on Full Extension — Why Infrapatellar Fat Pad (Hoffa’s Fat Pad) Impingement Syndrome Should Not Be Confused With Knee Osteoarthritis or Patellofemoral Osteoarthritis: Dr. Moriwaki Organizes the Chronic Inflammation and Fibrosis Behind Anterior Knee Pain That Worsens in Extension, and the Line Between What Stem Cell Conditioned Media Knee Injection Can Address (Intra-articular Inflammatory Environment) and What It Cannot (Structural Compression)2026.08.04
A sharp ache under the kneecap when you fully straighten the leg, a heavy, dull anterior knee pain after prolonged standing, or a snagging pain going down stairs — behind these anterior knee complaints is often a distinct clinical entity separate from knee osteoarthritis: infrapatellar fat pad impingement (also called Hoffa’s fat pad impingement, or Hoffa syndrome). The infrapatellar fat pad is a highly vascularized and innervated adipose tissue wedged behind the patellar tendon and in front of the femur and tibia, with a structure especially prone to repeated micro-compression and inflammation. In this article, Dr. Moriwaki of AVAN TOKYO Ginza organizes the pathology of infrapatellar fat pad impingement and delineates the scope of intra-articular inflammatory control that stem cell conditioned media knee injection can address, and the limits it cannot reach — namely structural compressive factors.
Key Points
・Infrapatellar fat pad impingement is an independent condition that causes sharp anterior knee pain in full extension or hyperextension, and it should be clinically distinguished from knee osteoarthritis and patellofemoral osteoarthritis as a cause of anterior knee pain.
・The infrapatellar fat pad is richly innervated with Substance P- and CGRP-positive nerve endings and reacts sensitively to inflammation and fibrosis, so chronic impingement readily spreads into an intra-articular synovitis cycle.
・Stem cell conditioned media knee injection has a pathophysiologic affinity for correcting this intra-articular inflammatory cycle, but it is not a treatment that removes structural compressive factors such as patella baja, fat pad calcification, or ligamentous malalignment.
・Diagnosis relies on a positive Hoffa test (pain reproduced when the sides of the patellar tendon are compressed in full extension) together with MRI T2-weighted images showing high-signal and hypertrophied fat pad.
・The reasonable sequence is to build a foundation of conservative care — movement-pattern correction, quadriceps re-education, bracing, NSAIDs — and then add stem cell conditioned media knee injection as a step to settle the inflammatory cycle.
What Is the Infrapatellar Fat Pad (Hoffa’s Fat Pad)?
The infrapatellar fat pad is a triangular adipose tissue wedged among the patellar tendon, the joint capsule, the intercondylar area of the femur, and the anterior tibial intercondylar eminence. It changes shape with knee flexion and extension while serving as an intra-articular cushion, a vascular reservoir, and a source of joint-lubricating factors. Histologically, arterioles and capillary networks develop between adipocytes, and it is distinctively rich in Substance P- and CGRP-positive nerve endings — arguably one of the most pain-sensitive tissues within the knee joint.
Why It Easily Becomes a “Pain-Generating Tissue”
When the knee is hyperextended, the infrapatellar fat pad becomes pinched between the patellofemoral and tibiofemoral joints; repeated events cause minor compression and local microcirculatory disturbance. When chronic, fibrosis and hypertrophy progress inside the fat pad, and it becomes even more easily pinched in extension — a vicious loop. Because the fat pad is continuous with the synovium, inflammation arising in the fat pad readily spreads to intra-articular synovitis, secondarily driving an inflammatory cycle across the entire knee joint cavity. In younger patients, jumping and running produce hyperextension loading; in middle-aged and older patients, prolonged standing with the knees locked and postural patella baja are common backgrounds.
Differentiating From Knee Osteoarthritis and Patellofemoral Osteoarthritis — Don’t Lump Anterior Knee Pain Together
Anterior knee pain is a region where multiple pathologies can overlap — knee osteoarthritis, patellofemoral osteoarthritis, patellar tendinopathy (jumper’s knee), and infrapatellar fat pad impingement. In clinical practice they are often lumped as “early knee osteoarthritis,” but to separate treatment design one must carefully gather clinical findings.
Distinguishing Clinical Features
・Knee osteoarthritis (medial type): medial joint line pain, varus deformity, medial pain when descending stairs
・Patellofemoral osteoarthritis: retropatellar pain on stair climbing and squatting, increased Q angle
・Patellar tendinopathy (jumper’s knee): tenderness at the inferior pole of the patellar tendon, worsening with jumping and landing
・Infrapatellar fat pad impingement: sharp anterior knee pain (in the recesses on either side of the patellar tendon) in full extension or hyperextension, positive Hoffa test, worsening with prolonged standing or the locked-knee position
How to Position Imaging Findings
On MRI, T2-weighted images show high signal in the infrapatellar fat pad, and chronic cases exhibit fat pad hypertrophy and fibrotic changes below the patellar tendon. Plain X-ray may show intrafatpad calcification (Hoffa’s fat pad calcification) as an indirect chronic-phase sign. Please also refer to the Japanese Orthopaedic Association for guidance on joint disease. That said, imaging is only supportive; the diagnosis pivots on correlating the imaging with the clinical picture — pain reproduced in extension and the patient’s movement pattern.
What Stem Cell Conditioned Media Knee Injection Can and Cannot Address
Stem cell conditioned media contains anti-inflammatory cytokines (IL-1 receptor antagonist-like molecules, TGF-β, HGF, etc.) and growth factors that are thought to act on intra-articular synovial cells, chondrocytes, and adipocytes to mitigate inflammatory cycles and normalize the tissue remodeling environment. Because the chronic pathology of infrapatellar fat pad impingement is a loop of “mechanical compression → fibrosis → inflammation → synovitis spread,” intervening in the intra-articular inflammatory cycle with a stem cell conditioned media knee injection is pathophysiologically congruent.
Addressable Scope (Correcting the Intra-articular Inflammatory Environment)
・Reduction of secondary synovitis, easing joint effusion and morning stiffness
・Calming acute inflammation around the fat pad, with corresponding improvement in pain scores
・Preparing a “movable joint” that can accept exercise therapy and bracing
Non-Addressable Scope (Structural Compressive Factors)
・Anatomic correction of patella baja itself
・Complete removal of hypertrophied and fibrotic scar tissue at the inferior pole of the patellar tendon
・Ligamentous malalignment that produces hyperextension
・Mechanical compression from advanced fat pad calcification or osteophyte formation
In cases dominated by structural factors, even if stem cell conditioned media knee injection temporarily calms inflammation, symptoms flare again once daily activities repeat the compression. Realistically it should be positioned as “a combined treatment at the phase where you cut the inflammation and restore movement,” with individual variability in response and no guarantee of efficacy for every case.
Sequencing of Treatment Design — Layering Stem Cell Conditioned Media on the Conservative Base
Treatment for infrapatellar fat pad impingement begins with correcting movement patterns that cause hyperextension (habitual locked-knee standing, stair-descent form), re-educating the quadriceps (especially the vastus medialis) and hip-girdle muscles, and self-mobilization to preserve patellar mobility. Oral and topical NSAIDs are used short-term during acute flare-ups, and orthoses (patellar tendon straps, mild flexion braces) reduce repeated mechanical compression.
On that foundation, adding stem cell conditioned media knee injection makes clinical sense in cases where the pain and synovitis cycle persist and limit daily activity. Corticosteroid intra-articular injection is potent for short-term inflammation control, but risks such as fat pad atrophy and subcutaneous dimpling make it hard to repeat. Stem cell conditioned media has fewer reports of tissue-atrophy risk and has affinity with this condition, which often requires multi-session treatment design over a chronic course — but it should be positioned as a supplement built on conservative care. Please see details on joint injection with stem cell conditioned media for the overall positioning of the treatment.
Frequently Asked Questions
Q. If left untreated, will infrapatellar fat pad impingement progress to knee osteoarthritis?
Because chronic fat pad inflammation spreads to intra-articular synovitis, it can act as a contributing factor to long-term knee osteoarthritis progression. However, it cannot be asserted that an isolated lesion inevitably transitions to knee osteoarthritis; many cases can be stabilized long-term with movement correction and inflammation control.
Q. How many sessions of stem cell conditioned media knee injection are typically needed?
Sessions vary by chronicity, symptom severity, and coexisting pathology. A common design is several sessions in an induction phase, then consideration of maintenance dosing based on follow-up. Efficacy is assessed by pain score, extension range of motion, and recovery of daily activities; if response is poor, the treatment plan should be reconsidered.
Q. How should corticosteroid intra-articular injection and stem cell conditioned media be used differently?
Corticosteroid injection can be useful when short-term calming of acute inflammation is the goal, but it is not suited to long-term strategy given its impact on fat pad tissue. For settling the chronic inflammatory cycle, stem cell conditioned media can be a viable option. The two have different aims, and it is more realistic to use them by phase rather than as replacements for one another.
Q. How does this compare with arthroscopic partial fat pad resection?
Arthroscopic resection may be indicated when marked fat pad hypertrophy or calcification does not respond to conservative care. Stem cell conditioned media knee injection is an option at the stage of first trying to achieve inflammation and function improvement with conservative care; clinically it is positioned as a way to “buy time” while judging surgical indication, not as a binary choice between surgery and injection.
Q. Is it safe to continue exercising during treatment?
Movements that force hyperextension (prolonged locked-knee standing, static holds at the bottom of a deep squat) are best avoided. Aerobic exercise that moves the knee in slight flexion — walking, light cycling, water exercise — is beneficial for inflammation control and quadriceps re-education, and continuation is recommended in most cases.
──────────────
Supervising Physician: Shin Moriwaki, MD
Member, Japan Society of Aesthetic Surgery (JSAS)
Member, American Academy of Aesthetic Medicine
ECFMG Certificate (U.S. Medical License Qualification)
──────────────
📍AVAN TOKYO 銀座 再生医療
AVAN TOKYO Ginza Regenerative Medicine
English / 中文 / Tiếng Việt available
For consultations, please contact us via DM / LINE / Website / Phone.